Skip to content

A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma

A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05620420
Enrollment
501
Registered
2022-11-17
Start date
2022-11-08
Completion date
2023-11-07
Last updated
2024-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, Psychological Distress, Somatic Symptoms

Keywords

multiple myeloma, mental health

Brief summary

Multiple myeloma patients with normal ability of communication and understanding will be enrolled. DT, GAD-7, PHQ-15 and PSQI scales are designed to assess the mental health status of the patients. Demographic and disease data of patients will be collected as well. The main aim is to explore the factors affecting the mental health of myeloma patients.

Interventions

None listed

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients with symptomatic multiple myeloma were diagnosed according to the criteria of Chinese multiple myeloma diagnosis and treatment guidelines (revised in 2022). 2. Age ≥18 years, with junior high school education or above. Patients have normal ability of communication and understanding. 3. Informed consent has been signed.

Exclusion criteria

1. Who has kinship with other enrolled patients. 2. Life expectancy of\< 6 months.

Design outcomes

Primary

MeasureTime frameDescription
morbidity of psychological distress in patients with multiple myeloma.Baseline (the time when the patient is enrolled to the study)The total score of DT scale ≥4 points is defined as obviously psychological distress.

Secondary

MeasureTime frameDescription
morbidity of anxiety in patients with multiple myeloma.Baseline (the time when the patient is enrolled to the study)GAD-7 scale is applied to assess the anxiety of the patient
morbidity of insomnia in patients with multiple myeloma.Baseline (the time when the patient is enrolled to the study)PSQI scale is applied to assess the insomnia of the patient

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026